ReviewFrontiers in endocrinology2026
The therapeutic potential of descending regulatory pathways from brain to bone in osteoporosis: focusing on the brain-bone axis.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoporosis (OP) is a growing global health concern, characterized by reduced bone mass, deterioration of bone microarchitecture, and consequently increased bone fragility. The brain-bone axis, a complex regulatory network encompassing the nervous, endocrine, and immune systems, elucidates the central role of the brain in regulating bone homeostasis. Consequently, this axis has become a major focus of interdisciplinary research into the pathogenesis of OP. However, the current understanding of the descending regulatory pathways from the brain to the bone remains incomplete. Therefore, this paper preliminarily explores the mechanisms and experimental evidence of different descending regulatory pathways from a new perspective. It integrates multiple descending regulatory pathways, discusses some of their interrelationships, and reveals the complex network nature of central bone metabolism regulation. Our objective is to elucidate the role of the central nervous system (CNS) in OP pathogenesis, thereby offering new insights and directions for future research on its prevention and treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.